EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis

Baha Moshiree, A Jay Freeman, Phuong T Vu, Umer Khan, Carmen Ufret-Vincenty, Sonya L Heltshe, Christopher H Goss, Sarah Jane Schwarzenberg, Steven D Freedman, Drucy Borowitz, Meghana Sathe, GALAXY Study Group

Journal of Cystic Fibrosis · 2023-03 · 22 (2) · 266-274

DOI: 10.1016/j.jcf.2022.10.006 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cystic Fibrosis, 2023-03. Verfasst von Baha Moshiree und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Atrium Health, Charlotte, NC, United States. Electronic address: Baha…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Gastrointestinal Diseases. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Cystic Fibrosis Foundation, Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: People with cystic fibrosis (PwCF) suffer from gastrointestinal (GI) symptoms affecting their quality of life (QOL). Despite the relevance of GI symptoms to the overall health of PwCF, a paucity of studies only have comprehensively assessed the prevalence, severity and QOL of GI symptoms in both children and adults with Cystic Fibrosis (CF). METHODS: Eligible participants ≥2 years of age across 26 US CF centers were followed for 4 weeks. Three validated GI electronic patient-reported outcome measures (ePROMs) with a recall period of 2 weeks and a stool-specific questionnaire were administered weekly over four weeks. Total and domain scores of ePROMs were evaluated overall and in subgroups using linear mixed-effect models. RESULTS: Of 402 enrolled, 58% were ≥ 18 years of age (52% male). The mean (SD) of the total score for PAC-SYM was 0.52 (0.55), for PAGI-SYM was 0.63 (0.67), and for PAC-QOL was 0.67 (0.55). For specific ePROM questions, prevalence of moderate to very severe symptoms were as follows: straining (20.3%), fullness (18.3%), incomplete bowel movements (17.1%), bloating (16.4%), distension (16.4%), abdominal pain (upper-5.1%, lower-7.5%). Comparing participants ≥18 versus

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisGastrointestinal DiseasesAdultChildHumansMaleFemaleInfantQuality of LifeProspective StudiesAbdominal Pain

Stichwörter der Autor:innen

ConstipationCystic fibrosisGastrointestinal questionnairesGastrointestinal symptomsPatient-reported outcome measures

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Atrium Health, Charlotte, NC, United States. Electronic address: Baha.moshiree@atriumhealth.org.
  • Division of Pediatric Gastroenterology, Nationwide Children's Hospital/The Ohio State University, Columbus, OH, United States.
  • Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, United States.
  • Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle WA, United States; Department of Pediatrics, University of Washington School of Medicine, S…
  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States.
  • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, United States.

Förderung

  • NIDDK NIH HHS
  • Cystic Fibrosis Foundation
  • Gilead Sciences
  • National Institutes of Health

Zitieren

APA

Moshiree, B., Freeman, A. J., Vu, P. T., Khan, U., Ufret-Vincenty, C., Heltshe, S. L., Goss, C. H., Schwarzenberg, S. J., Freedman, S. D., Borowitz, D., Sathe, M., & GALAXY Study Group (2023). Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis. Journal of Cystic Fibrosis, 22(2), 266-274. https://doi.org/10.1016/j.jcf.2022.10.006

Vancouver

Moshiree B, Freeman AJ, Vu PT, Khan U, Ufret-Vincenty C, Heltshe SL, et al. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis. Journal of Cystic Fibrosis. 2023;22(2):266-274. doi:10.1016/j.jcf.2022.10.006

BibTeX
@article{Moshiree2023,
  author = {Moshiree, Baha and Freeman, A Jay and Vu, Phuong T and Khan, Umer and Ufret-Vincenty, Carmen and Heltshe, Sonya L and Goss, Christopher H and Schwarzenberg, Sarah Jane and Freedman, Steven D and Borowitz, Drucy and Sathe, Meghana and GALAXY Study Group, GALAXY Study Group},
  title = {Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis},
  journal = {Journal of Cystic Fibrosis},
  year = {2023},
  volume = {22},
  number = {2},
  pages = {266--274},
  doi = {10.1016/j.jcf.2022.10.006}
}
Kostenlos starten →